Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)

Clinical trial NCT00254696 · COMPLETED

Trial details

NCT number: NCT00254696
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bacterial Infection

Start date: 2004-06-01
Primary completion: 2005-03-01
Enrollment: 710

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.